KRYS vs SYK · P/E 46, rev $235.6M vs P/E 35, rev $6.59B
Krystal Biotech Inc (KRYS) versus Stryker Corporation (SYK) — a side-by-side from cached financials, not a winner call.
Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
Stryker Corporation (SYK) is a medical devices company listed on NYSE.
Latest reported KRYS revenue for 2026-06-30 was $235.6M. Net income was $110.7M. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
Latest reported SYK revenue for 2026-06-30 was $6.59B. Net income was $1.28B. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
KRYS currently screens at market cap $10.17B and trailing P/E 46.1. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
Not investment advice. Open the KRYS and SYK stock pages for the full models.
Not investment advice.